Tested Applications
| Positive WB detected in | BxPC-3 cells, human stomach tissue, SGC-7901 cells |
| Positive IHC detected in | mouse brain tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | BxPC-3 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:200-1:800 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:10-1:100 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
16549-1-AP targets CCKBR-specific in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | cholecystokinin B receptor |
| Calculated Molecular Weight | 56 kDa |
| Observed Molecular Weight | 64 kDa, 50 kDa |
| GenBank Accession Number | NM_176875 |
| Gene Symbol | CCKBR |
| Gene ID (NCBI) | 887 |
| RRID | AB_2070508 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P32239 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
The cholecystokinin B receptor (CCKBR) is a G-protein coupled receptor for gastrin and cholecystokinin (CCK), regulatory peptides of the brain and gastrointestinal tract. This protein is a type B gastrin receptor, which has a high affinity for both sulfated and nonsulfated CCK analogs and is found principally in the central nervous system and the gastrointestinal tract. A misspliced transcript variant including an intron has been observed in cells from colorectal and pancreatic tumors.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for CCKBR-specific antibody 16549-1-AP | Download protocol |
| IHC protocol for CCKBR-specific antibody 16549-1-AP | Download protocol |
| WB protocol for CCKBR-specific antibody 16549-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The anti-CCK2R antibody (Cat# 16549-1-AP) has 3 total citations. These publications appear in Cell (IF 45.1), Molecular Pharmaceutics (IF 4.9), and Journal of Cancer Research and Clinical Oncology (IF 3.3). The associated research fields include Alzheimer's disease treatment via biased CCKBR agonism, and colorectal cancer diagnostics and immunotherapy targeting CCK2R-expressing malignancies. Applications span WB, IHC, and IF in both mouse and human samples.
| Species | Application | Title |
|---|---|---|
Cell Elucidating pathway-selective biased CCKBR agonism for Alzheimer's disease treatment. | ||
Mol Pharm Pseudomonas Exotoxin A-Based Immunotherapy Targeting CCK2R-Expressing Colorectal Malignancies: An In Vitro and In Vivo Evaluation. | ||
J Cancer Res Clin Oncol Cholecystokinin type 2 receptor in colorectal cancer: diagnostic and therapeutic target. |











